[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@BioMedWire BioMedWire
BioMedWire posts on X about $mrk, $azn, india, gambia the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX +4.40%
- X Month XXXXX +23%
- X Months XXXXXX +55%
- X Year XXXXXX +135%
Mentions: XX #
- X Week X -XX%
- X Month XX -XX%
- X Months XXX -XXXX%
- X Year XXX +30%
Followers: XXXXX #
- X Week XXXXX -XXXX%
- X Month XXXXX no change
- X Months XXXXX +0.62%
- X Year XXXXX +0.86%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence stocks X% currencies X% countries XXX% finance XXX% cryptocurrencies XXX%
Social topic influence $mrk #33, $azn #62, india 0.8%, gambia 0.4%, unite 0.4%, $sngx 0.4%, bp 0.4%, momentum 0.4%, stockmarket 0.4%, $beat XXX%
Top accounts mentioned or mentioned by @marketwirenews
Top assets mentioned Merck & Co., Inc. (MRK) AstraZeneca PLC (AZN) MetaBeat (BEAT)
Top Social Posts #
Top posts by engagements in the last XX hours
"$MRK Foundation co-hosts the 12th Africa Asia Luminary in Banjul The Gambia with First Lady Fatoumatta Bah-Barrow. Over 6000 global leaders unite for healthcare and women's empowerment: #MerckFoundation #AfricaAsiaLuminary #HealthcareLeadership"
X Link @BioMedWire 2025-10-15T14:00Z 1299 followers, XX engagements
"$MRK showcases new data on HIV treatment and prevention at EACS 2025 featuring DOR/ISL and MK-8591D trials. Advancing the fight against HIV with innovative therapies: #Merck #EACS2025 #HIVResearch #InnovativeTherapies #DORISL #MK8591D"
X Link @BioMedWire 2025-10-13T14:00Z 1298 followers, XXX engagements
"$SNGX Closes Multimillion-Dollar Public Offering to Fund Pipeline Through 2026"
X Link @BioMedWire 2025-10-13T19:30Z 1297 followers, XX engagements
"$AZN baxdrostat showed substantial blood pressure reduction in treatment-resistant hypertensionpotential new option for patients whose BP remains uncontrolled: #Hypertension #BloodPressure #CardioResearch #PharmaInnovation"
X Link @BioMedWire 2025-10-07T18:00Z 1297 followers, XX engagements
"$MRK Keytruda Qlex secures FDA approval for subcutaneous use in XX solid tumor indications enhancing patient convenience and extending patent protection: #Merck #KeytrudaQlex #FDAApproval #CancerTreatment #OncologyInnovation #MRKStock"
X Link @BioMedWire 2025-10-14T14:00Z 1297 followers, XX engagements
"$MRK reports win from its Phase X HYPERION trial: WINREVAIR cut risk of clinical worsening by XX% benefit evident within X weeks: #Pharma #ClinicalTrials #PAH #Winrevair #Merck"
X Link @BioMedWire 2025-10-02T15:00Z 1297 followers, XX engagements
"$AZN Young Health Programme empowers India's youth to combat NCDs through peer education community engagement and skill-building. By addressing risk factors early it fosters healthier futures: #AstraZeneca #YouthHealth #NCDPrevention #India"
X Link @BioMedWire 2025-10-13T18:00Z 1297 followers, XX engagements
"$AZN strikes a deal with Trump agreeing to offer discounts to Medicaid in return for tariff relief: #DrugPrices #Medicaid #HealthPolicy #AstraZenecaDeal"
X Link @BioMedWire 2025-10-12T18:00Z 1298 followers, XXX engagements
"$AZN Pharma India has shifted its technical trend from mildly bullish to bullish reflecting strong performance and positive momentum: #AstraZeneca #PharmaIndia #StockMarket #TechnicalAnalysis #BullishTrend #Investing"
X Link @BioMedWire 2025-10-15T18:00Z 1299 followers, XX engagements
"MissionIRNewsBreaks $BEAT on the Beat of Cardiac Innovation"
X Link @BioMedWire 2025-10-08T19:32Z 1297 followers, XX engagements
"$AZN showcases pivotal trial data at ESMO 2025 focusing on breast bladder and gastric cancers. Collaborations with Daiichi Sankyo Merck & Co. and HUTCHMED enhance their oncology portfolio: #AstraZeneca #ESMO2025 #CancerCare #OncologyResearch"
X Link @BioMedWire 2025-10-14T18:00Z 1297 followers, XXX engagements
"$MRK KGaA integrates Quris Bio-AI platform to enhance drug safety predictions and reduce animal testing. This collaboration aims to streamline clinical trial readiness by assessing preclinical candidates' liver toxicity risks: #PharmaInnovation #Merck"
X Link @BioMedWire 2025-09-30T14:00Z 1299 followers, 2793 engagements